Literature DB >> 20226873

Linking structure and function in glaucoma.

R S Harwerth1, J L Wheat, M J Fredette, D R Anderson.   

Abstract

The glaucomas are a group of relatively common optic neuropathies, in which the pathological loss of retinal ganglion cells causes a progressive loss of sight and associated alterations in the retinal nerve fiber layer and optic nerve head. The diagnosis and management of glaucoma are often dependent on methods of clinical testing that either, 1) identify and quantify patterns of functional visual abnormality, or 2) quantify structural abnormality in the retinal nerve fiber layer, both of which are caused by loss of retinal ganglion cells. Although it is evident that the abnormalities in structure and function should be correlated, propositions to link losses in structure and function in glaucoma have been formulated only recently. The present report describes an attempt to build a model of these linking propositions using data from investigations of the relationships between losses of visual sensitivity and thinning of retinal nerve fiber layer over progressive stages of glaucoma severity. A foundation for the model was laid through the pointwise relationships between visual sensitivities (behavioral perimetry in monkeys with experimental glaucoma) and histological analyses of retinal ganglion cell densities in corresponding retinal locations. The subsequent blocks of the model were constructed from clinical studies of aging in normal human subjects and of clinical glaucoma in patients to provide a direct comparison of the results from standard clinical perimetry and optical coherence tomography. The final formulation is a nonlinear structure-function model that was evaluated by the accuracy and precision of translating visual sensitivities in a region of the visual field to produce a predicted thickness of the retinal nerve fiber layer in the peripapillary sector that corresponded to the region of reduced visual sensitivity. The model was tested on two independent patient populations, with results that confirmed the predictive relationship between the retinal nerve fiber layer thickness and visual sensitivities from clinical perimetry. Thus, the proposed model for linking structure and function in glaucoma has provided information that is important in understanding the results of standard clinical testing and the neuronal losses caused by glaucoma, which may have clinical application for inter-test comparisons of the stage of disease. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20226873      PMCID: PMC2878911          DOI: 10.1016/j.preteyeres.2010.02.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  110 in total

1.  3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: prelaminar neural tissues and cupping.

Authors:  Hongli Yang; J Crawford Downs; Anthony Bellezza; Hilary Thompson; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

2.  Modeling the effects of aging on retinal ganglion cell density and nerve fiber layer thickness.

Authors:  Ronald S Harwerth; Joe L Wheat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-13       Impact factor: 3.117

Review 3.  A framework for comparing structural and functional measures of glaucomatous damage.

Authors:  Donald C Hood; Randy H Kardon
Journal:  Prog Retin Eye Res       Date:  2007-08-21       Impact factor: 21.198

4.  Topography of the retina and striate cortex and its relationship to visual acuity in rhesus monkeys and squirrel monkeys.

Authors:  E T Rolls; A Cowey
Journal:  Exp Brain Res       Date:  1970       Impact factor: 1.972

5.  Retinal nerve fiber structure versus visual field function in patients with ischemic optic neuropathy. A test of a linear model.

Authors:  Donald C Hood; Susan Anderson; Jacinthe Rouleau; Adam S Wenick; Larissa K Grover; Myles M Behrens; Jeffrey G Odel; Andrew G Lee; Randy H Kardon
Journal:  Ophthalmology       Date:  2007-09-17       Impact factor: 12.079

6.  A visual field index for calculation of glaucoma rate of progression.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Am J Ophthalmol       Date:  2008-02       Impact factor: 5.258

7.  Charles F. Prentice Award Lecture 2006: a neuron doctrine for glaucoma.

Authors:  Ronald S Harwerth
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

8.  Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes.

Authors:  Donald L Budenz; Marie-Josée Fredette; William J Feuer; Douglas R Anderson
Journal:  Ophthalmology       Date:  2007-08-13       Impact factor: 12.079

9.  Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm.

Authors:  Marie-Josée Fredette; Douglas R Anderson; Vittorio Porciatti; William Feuer
Journal:  Ophthalmology       Date:  2007-11-05       Impact factor: 12.079

10.  Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection.

Authors:  Mitra Sehi; Dilraj S Grewal; Clinton W Sheets; David S Greenfield
Journal:  Am J Ophthalmol       Date:  2009-07-09       Impact factor: 5.258

View more
  138 in total

1.  Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-04       Impact factor: 4.799

2.  Retinal ganglion cell and inner plexiform layer thickness measurements in regions of severe visual field sensitivity loss in patients with glaucoma.

Authors:  A L de A Moura; A S Raza; M A Lazow; C G De Moraes; D C Hood
Journal:  Eye (Lond)       Date:  2012-06-15       Impact factor: 3.775

3.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

4.  Structure-function relationships using the Cirrus spectral domain optical coherence tomograph and standard automated perimetry.

Authors:  Mauro T Leite; Linda M Zangwill; Robert N Weinreb; Harsha L Rao; Luciana M Alencar; Felipe A Medeiros
Journal:  J Glaucoma       Date:  2012-01       Impact factor: 2.503

5.  Relationship Between Central Retinal Vessel Trunk Location and Visual Field Loss in Glaucoma.

Authors:  Mengyu Wang; Hui Wang; Louis R Pasquale; Neda Baniasadi; Lucy Q Shen; Peter J Bex; Tobias Elze
Journal:  Am J Ophthalmol       Date:  2017-01-11       Impact factor: 5.258

6.  Estimation of retinal ganglion cell loss in glaucomatous eyes with a relative afferent pupillary defect.

Authors:  Andrew J Tatham; Daniel Meira-Freitas; Robert N Weinreb; Amir H Marvasti; Linda M Zangwill; Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

7.  Sustained ocular hypertension induces dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location.

Authors:  Liang Feng; Yan Zhao; Miho Yoshida; Hui Chen; Jessica F Yang; Ted S Kim; Jianhua Cang; John B Troy; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-07       Impact factor: 4.799

8.  Blur-resistant perimetric stimuli.

Authors:  Douglas G Horner; Mitchell W Dul; William H Swanson; Tiffany Liu; Irene Tran
Journal:  Optom Vis Sci       Date:  2013-05       Impact factor: 1.973

9.  Estimating the rate of retinal ganglion cell loss in glaucoma.

Authors:  Felipe A Medeiros; Linda M Zangwill; Douglas R Anderson; Jeffrey M Liebmann; Christopher A Girkin; Ronald S Harwerth; Marie-Josée Fredette; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2012-07-27       Impact factor: 5.258

10.  Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma.

Authors:  Felipe A Medeiros; Renato Lisboa; Robert N Weinreb; Jeffrey M Liebmann; Christopher Girkin; Linda M Zangwill
Journal:  Ophthalmology       Date:  2012-12-12       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.